Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: Czechia Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20031
20042
20052
20062
20071
20083
20093
20103
20123
20132
20141
20154
20163
20174
20181
20194
20204
20213
20224
20231
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status11
Recruiting6
Terminated6
Active, not recruiting4
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S10
Charles University, Czech Republic6
Sanofi5
University Hospital, Motol5
Eli Lilly and Company4
Institute for Clinical and Experimental Medicine3
Andromeda Biotech Ltd.2
Boehringer Ingelheim2
Diamyd Medical AB2
Gan and Lee Pharmaceuticals, USA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 167
Diabetes Mellitus21
Diabetes Mellitus, Type 210
Autoimmune Diseases3
Insulin Resistance3
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Diabetic Nephropathies2
Hypoglycemia2
Immune System Diseases2

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.